Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance.
about
Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trialsMelatonin as a Potential Agent in the Treatment of SarcopeniaThe renin-angiotensin system and prevention of age-related functional decline: where are we now?ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.Toward an integrated research agenda for critical illness in agingCarla Task Force on Sarcopenia: propositions for clinical trialsDifferential effects of enalapril and losartan on body composition and indices of muscle quality in aged male Fischer 344 × Brown Norway rats.Usefulness of preclinical models for assessing the efficacy of late-life interventions for sarcopeniaArterial stiffness and gait speed in older adults with and without peripheral arterial diseaseSarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopeniaGrip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study.Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearanceAngiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise.Late-life enalapril administration induces nitric oxide-dependent and independent metabolic adaptations in the rat skeletal muscle.Antihypertensive Use and the Effect of a Physical Activity Intervention in the Prevention of Major Mobility Disability Among Older Adults: The LIFE Study.Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectivesTargeting inflammation to slow or delay functional decline: where are we?Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease.Predictors of Change in Physical Function in Older Adults in Response to Long-Term, Structured Physical Activity: The LIFE Study.Is there a new role for angiotensin-converting-enzyme inhibitors in elderly patients?Effects of enalapril or nifedipine on muscle strength or functional capacity in elderly subjects. A double blind trial.Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats.Dietary amelioration of locomotor, neurotransmitter and mitochondrial aging.Chymase-dependent production of angiotensin II: an old enzyme in old hearts.Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: an observational study.The role of the cell-matrix interface in aging and its interaction with the renin-angiotensin system in the aged vasculature.
P2860
Q27022354-85D75196-EA6C-4915-B4CF-51342C2B06E9Q28076649-AB3435D1-7E31-43B6-AA1E-D95BB98FAFBCQ28085528-18385B86-D667-4B95-BC82-75A136800EACQ33636677-16533BF6-9686-4956-A099-CCF15A1558E5Q34268968-928A69EE-366D-4A56-8C68-7D134A4A67DFQ35031618-356EFFB0-8E8B-4500-9039-4050F9FCA5C5Q35080208-8E8467F5-EBD6-4220-BB46-D2A4CCDF0116Q35678546-D204752B-A23D-4F3D-A2B0-104D54BD1482Q35790939-F58910F3-DC6F-4894-9D8B-D3C237868568Q36039024-08CFC7DE-6ACE-4F81-BEDB-0D14CBEE6506Q36537163-FFD5C990-E650-48F6-A3CE-D9FF6E5016ABQ36638764-AE1B5C5E-B444-45C3-A55F-9BB1E0DAC3F2Q36764607-6609E83E-EDEA-4F5B-B2EB-865B6840FF77Q36993333-0ED0E66C-B391-441E-8F08-B4DBC5208F64Q37000459-15EFA8F5-7D33-4E8F-A836-B834453C41C3Q37211844-1793F547-6000-442D-A9A5-520F346B1971Q37765193-6DD3BC9B-0890-4A85-85AD-B355B7533E5EQ38023517-F4BC9D58-C616-40D6-9186-D446BA95066BQ40604606-C493BD36-A83B-4201-AB98-B4EC9F32626EQ41495992-82030101-E668-44A0-BE84-E174D77913E3Q45979864-4BBDB60D-6730-4BBC-938F-E7A44F1BE0CCQ46433134-D24A4AC0-5DC2-41E7-88BB-9EC0937185D3Q48216539-80B512AA-2B72-49CE-83CE-7C93A67C0B12Q51343625-CE0A8A37-30A7-40DA-BE83-A2836BCF1BE4Q51893818-493C18D2-F429-45D9-BFDF-F4A20203E993Q52601427-021E4FED-6CA4-408C-9ABE-AF74AB828D7C
P2860
Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Angiotensin-converting enzyme ...... tion and physical performance.
@ast
Angiotensin-converting enzyme ...... tion and physical performance.
@en
type
label
Angiotensin-converting enzyme ...... tion and physical performance.
@ast
Angiotensin-converting enzyme ...... tion and physical performance.
@en
prefLabel
Angiotensin-converting enzyme ...... tion and physical performance.
@ast
Angiotensin-converting enzyme ...... tion and physical performance.
@en
P2093
P2860
P356
P1476
Angiotensin-converting enzyme ...... tion and physical performance.
@en
P2093
Christy S Carter
Graziano Onder
Marco Pahor
P2860
P304
P356
10.1093/GERONA/60.11.1437
P407
P577
2005-11-01T00:00:00Z